Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines.

导出 OA

翻译打印收藏纠错

作者： Julia R,Hirsiger ^[1] ; Maria,Martinez ^[2] ; Dimitrios A,Tsakiris ^[2] ; Micol G,Cittone ^[3] ; Lukas,Graf ^[4] ; Johannes,Oldenburg ^[5] ; Behnaz,Pezeshkpoor ^[5] ; Mike,Recher ^[6] ; Jens,Mueller ^[7] ; Bernhard,Gerber ^[5] ; Christoph T,Berger ^[3]

作者单位： Translational Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland. ^[1] Division of Hematology, University Hospital Basel, Basel, Switzerland. ^[2] Clinic of Hematology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland. ^[3] Hemophilia and Hemostasis Center, Centre for Laboratory Medicine, St. Gallen, Switzerland. ^[4] Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Medical Faculty, University of Bonn, Bonn, Germany. ^[5] Immunodeficiency, Department of Biomedicine, University of Basel, Basel, Switzerland. ^[6] University Center for Immunology, University Hospital Basel, Basel, Switzerland. ^[7] University of Zurich, Zurich, Switzerland. ^[8] Immunization Clinic, Medical Outpatient Clinic, University Hospital Basel, Basel, Switzerland. ^[9]

主题词因子Ⅷ(Factor VIII);血友病A(Hemophilia A);人类(Humans);RNA, 信使(RNA, Messenger)

DOI 10.1111/jth.15665

PMID 35108443

发布时间 2023-08-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交